1 / 14

Clinical Trial Supply Management: A virtual company’s l essons learned

Clinical Trial Supply Management: A virtual company’s l essons learned. Bruce H Morimoto, Ph.D. May 30, 2013. Disclaimer. The views expressed in this presentation are mine and do not reflect those of my past, present or future employers…. Senior Management View of CTS. Drug Manufacturing.

aric
Télécharger la présentation

Clinical Trial Supply Management: A virtual company’s l essons learned

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trial Supply Management: A virtual company’s lessons learned Bruce H Morimoto, Ph.D. May 30, 2013

  2. Disclaimer The views expressed in this presentation are mine and do not reflect those of my past, present or future employers…

  3. Senior Management View of CTS Drug Manufacturing Labeling Drug Depot Clinical Sites Devil is in the details… What’s so difficult?

  4. IMP Characteristics • Refrigerated storage product • Stability OK for up to 1M at RT • Not stable at > 40°C • Very expensive per unit cost • Limited supply (only 10% overage) • On-going stability—retest updates

  5. Clinical Trial Parameters • 48 sites, 6 countries, 3 continents • Study duration: 12 month • Recruitment: 9-12 months • ~300 subjects total • 0.5 subjects per month per site • IMP in 3 month kits

  6. IMP-Driven Decisions • Cold chain supply • Refrigerated shipping • Shipments needed to be temperature monitored • Just-in-time shipping • Couldn’t keep inventory at sites • Randomization would trigger shipping

  7. Trial-Driven Decisions • Product manufactured in North America • Continents • North America • Europe • Asia-Pacific • All countries in Europe part of EU (!) • Single QP release for all of Europe

  8. (Idealized) Product Flow Drug Manufacturing (North America) Labeling & Packaging (EU) QP Release Drug Depot (US) Drug Depot (EU) Drug Depot (Asia-Pacific) Clinicalsites Clinicalsites Clinicalsites

  9. Actual Product Flow Drug Manufacturing (North America) Bulk Drug (EU) Labeling & Packaging Placebo (NA) Labeling & Packaging Active (EU) QP Release Drug Depot (US) Drug Depot (Asia-Pacific) Drug Depot (EU) Clinicalsites Clinicalsites Clinicalsites

  10. Logistic Challenges • Customs • Multiple QP release • Volcanic eruptions • Find a customs broker—upfront! • Got bill for $200K • We were able to get most of it back, but… • Shipping-logistics expert (consultant)

  11. Case Challenge • Had 3 year stability on old formulation • Changed IMP formulation • IMP retest date driven by real-time stability • Get stability data from manufacturer • Update IMPD • Submit to European country authorities with proposed retest extension • Receive approval • Release newly labeled IMP into inventory • Shipped 3 month supply

  12. Lessons Learned • Have enough stability BEFORE you begin  • Map out supply chain and plan for contingencies • Independent person to track and review inventory & retest dates • Person needed to be unblinded to track placebo & active kits • Required excellent coordination with regulatory

  13. Other Learning Discussions • Shipping: • Premium provider versus Standard Courier • Just-in-time shipping versus inventory at sites • Cost of drug and availability • Cost of each shipment • Temperature monitoring • Bulk shipments versus Individual shipments • Temperature monitors versus warmmarks

  14. Special Thank You to:Tracey JoellLiam QuinnLesley ParkerSue Anne CrockerMina Virtusio Questions? Questions? Please email: bruce.morimoto@celerion.com

More Related